Communications Challenges for Health Care LeadersPosted by Janet Stacey on September 22, 2010 at 9:32 AM
The first few days of October will bring Life Science CEOs together in Phoenix to discuss regulations, reimbursement, commercialization and other challenges facing the industry. I look forward to connecting with many leaders in the medical device, pharmaceutical and biotech fields.
In advance of the event, I was interviewed about issues facing the industry. Listen to the podcast if you'd like to hear our thoughts on social media, crisis management and the impact of regulations.
Do you have other advice you'd offer life science leaders? Share your thoughts.
Crisis Management Wins and SinsPosted by Matt Kucharski on July 22, 2010 at 4:42 PM
Not since 9/11 have we seen this much interest among clients and prospects in crisis preparedness and management. As a direct result of BP (Exxon owes you a big thank-you, by the way), it only seems natural that boards and senior leadership teams are asking the "what if it were us" question.
While the BP situation is in many ways unprecedented, a lot of the "lessons learned" so far are really not new at all, but simply variations on the errors and best practices that should already be in place at progressive companies.
Here's a summary of what we've been using to help educate our clients on common errors and best practices:
Oh, and by the way, here's one I saw coming a mile away -- a bumper sticker on the back of a car that said "BP -- Beyond Pathetic"
Can't think of a more poignant example of a brand irrevocably damaged by a crisis...